Endogenous allosteric modulators of G protein-coupled receptors.

@article{Westhuizen2015EndogenousAM,
  title={Endogenous allosteric modulators of G protein-coupled receptors.},
  author={Emma T van der Westhuizen and C{\'e}line Valant and Patrick M. Sexton and Arthur Christopoulos},
  journal={The Journal of pharmacology and experimental therapeutics},
  year={2015},
  volume={353 2},
  pages={246-60}
}
G protein-coupled receptors (GPCRs) are the largest superfamily of receptors encoded by the human genome, and represent the largest class of current drug targets. Over the last decade and a half, it has become widely accepted that most, if not all, GPCRs possess spatially distinct allosteric sites that can be targeted by exogenous substances to modulate the receptors' biologic state. Although many of these allosteric sites are likely to serve other (e.g., structural) roles, they nonetheless… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis.

The international journal of biochemistry & cell biology • 2016
View 5 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 243 references

Antiinflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor

FA Pamplona, J Ferreira, +16 authors RN Takahashi
Proc Natl Acad Sci USA • 2012
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…